Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy

Paolo Moruzzi, Elisabetta Doria, Pier Giuseppe Agostoni, Vincenzo Capacchione, Paolo Sganzerla

Research output: Contribution to journalArticle

Abstract

The short-term effects of L-thyroxine (100 (μg/day, 10 patients) and placebo (10 patients) on idiopathic dilated cardiomyopathy were compared. Before and at the end of the treatment, a hemodynamic study was performed in the control state and during dobutamine infusion. A cardiopulmonary exercise test was also performed with hemodynamic monitoring. An echocardiogram was recorded in the control state and during acute changes of left ventricular afterload. Plasma levels of triiodothyronine, thyroxine, thyroid-stimulating hormone and norepinephrine were measured. Placebo was ineffective. After administration of L-thyroxine all patients had normal thyroid function. The increase in left ventricular ejection fraction and the rightward shift of the slope of left ventricular ejection fraction/end-systolic stress relation (p <0.05) indicated an improvement in the cardiac inotropic state. This proved to be independent of adrenergic influences by the unchanged β1 response to dobutamine. A decrease in resting systemic vascular resistances and an increase in cardiac output (p <0.05) were also observed. Cardiopulmonary effort parameters improved (p <0.05) without hemodynamic changes at peak exercise. It is concluded that L-thyroxine short-term administration improves cardiac and exercise performance in patients with chronic heart failure, without modifying the adrenergic support to the heart and the circulatory parameters at peak exercise.

Original languageEnglish
Pages (from-to)374-378
Number of pages5
JournalThe American Journal of Cardiology
Volume73
Issue number5
DOIs
Publication statusPublished - Feb 15 1994

Fingerprint

Dilated Cardiomyopathy
Thyroxine
Exercise
Dobutamine
Hemodynamics
Stroke Volume
Adrenergic Agents
Placebos
Triiodothyronine
Thyrotropin
Exercise Test
Cardiac Output
Vascular Resistance
Norepinephrine
Thyroid Gland
Heart Failure
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. / Moruzzi, Paolo; Doria, Elisabetta; Agostoni, Pier Giuseppe; Capacchione, Vincenzo; Sganzerla, Paolo.

In: The American Journal of Cardiology, Vol. 73, No. 5, 15.02.1994, p. 374-378.

Research output: Contribution to journalArticle

Moruzzi, Paolo ; Doria, Elisabetta ; Agostoni, Pier Giuseppe ; Capacchione, Vincenzo ; Sganzerla, Paolo. / Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. In: The American Journal of Cardiology. 1994 ; Vol. 73, No. 5. pp. 374-378.
@article{668d6622d73541a49eb19d4a6665e300,
title = "Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy",
abstract = "The short-term effects of L-thyroxine (100 (μg/day, 10 patients) and placebo (10 patients) on idiopathic dilated cardiomyopathy were compared. Before and at the end of the treatment, a hemodynamic study was performed in the control state and during dobutamine infusion. A cardiopulmonary exercise test was also performed with hemodynamic monitoring. An echocardiogram was recorded in the control state and during acute changes of left ventricular afterload. Plasma levels of triiodothyronine, thyroxine, thyroid-stimulating hormone and norepinephrine were measured. Placebo was ineffective. After administration of L-thyroxine all patients had normal thyroid function. The increase in left ventricular ejection fraction and the rightward shift of the slope of left ventricular ejection fraction/end-systolic stress relation (p <0.05) indicated an improvement in the cardiac inotropic state. This proved to be independent of adrenergic influences by the unchanged β1 response to dobutamine. A decrease in resting systemic vascular resistances and an increase in cardiac output (p <0.05) were also observed. Cardiopulmonary effort parameters improved (p <0.05) without hemodynamic changes at peak exercise. It is concluded that L-thyroxine short-term administration improves cardiac and exercise performance in patients with chronic heart failure, without modifying the adrenergic support to the heart and the circulatory parameters at peak exercise.",
author = "Paolo Moruzzi and Elisabetta Doria and Agostoni, {Pier Giuseppe} and Vincenzo Capacchione and Paolo Sganzerla",
year = "1994",
month = "2",
day = "15",
doi = "10.1016/0002-9149(94)90011-6",
language = "English",
volume = "73",
pages = "374--378",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy

AU - Moruzzi, Paolo

AU - Doria, Elisabetta

AU - Agostoni, Pier Giuseppe

AU - Capacchione, Vincenzo

AU - Sganzerla, Paolo

PY - 1994/2/15

Y1 - 1994/2/15

N2 - The short-term effects of L-thyroxine (100 (μg/day, 10 patients) and placebo (10 patients) on idiopathic dilated cardiomyopathy were compared. Before and at the end of the treatment, a hemodynamic study was performed in the control state and during dobutamine infusion. A cardiopulmonary exercise test was also performed with hemodynamic monitoring. An echocardiogram was recorded in the control state and during acute changes of left ventricular afterload. Plasma levels of triiodothyronine, thyroxine, thyroid-stimulating hormone and norepinephrine were measured. Placebo was ineffective. After administration of L-thyroxine all patients had normal thyroid function. The increase in left ventricular ejection fraction and the rightward shift of the slope of left ventricular ejection fraction/end-systolic stress relation (p <0.05) indicated an improvement in the cardiac inotropic state. This proved to be independent of adrenergic influences by the unchanged β1 response to dobutamine. A decrease in resting systemic vascular resistances and an increase in cardiac output (p <0.05) were also observed. Cardiopulmonary effort parameters improved (p <0.05) without hemodynamic changes at peak exercise. It is concluded that L-thyroxine short-term administration improves cardiac and exercise performance in patients with chronic heart failure, without modifying the adrenergic support to the heart and the circulatory parameters at peak exercise.

AB - The short-term effects of L-thyroxine (100 (μg/day, 10 patients) and placebo (10 patients) on idiopathic dilated cardiomyopathy were compared. Before and at the end of the treatment, a hemodynamic study was performed in the control state and during dobutamine infusion. A cardiopulmonary exercise test was also performed with hemodynamic monitoring. An echocardiogram was recorded in the control state and during acute changes of left ventricular afterload. Plasma levels of triiodothyronine, thyroxine, thyroid-stimulating hormone and norepinephrine were measured. Placebo was ineffective. After administration of L-thyroxine all patients had normal thyroid function. The increase in left ventricular ejection fraction and the rightward shift of the slope of left ventricular ejection fraction/end-systolic stress relation (p <0.05) indicated an improvement in the cardiac inotropic state. This proved to be independent of adrenergic influences by the unchanged β1 response to dobutamine. A decrease in resting systemic vascular resistances and an increase in cardiac output (p <0.05) were also observed. Cardiopulmonary effort parameters improved (p <0.05) without hemodynamic changes at peak exercise. It is concluded that L-thyroxine short-term administration improves cardiac and exercise performance in patients with chronic heart failure, without modifying the adrenergic support to the heart and the circulatory parameters at peak exercise.

UR - http://www.scopus.com/inward/record.url?scp=0027979425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027979425&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(94)90011-6

DO - 10.1016/0002-9149(94)90011-6

M3 - Article

C2 - 8109552

AN - SCOPUS:0027979425

VL - 73

SP - 374

EP - 378

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -